Will I resolve more complex problems?
Different practices. One analysis. Your solution.
The Life Sciences Practice is composed of 30 specialists experienced in pharmaceutical and biotechnology law, food law, anti-monopoly law, healthcare and constitutional law.
We advise Polish and foreign entities in the pharmaceutical, healthcare, food and chemical sectors, and companies in the alcohol and tobacco industries.
We specialise in strategic advice in the areas of legislation, reimbursement, distribution, telemedicine solutions and compliance.
Our clients are local government authorities, which we advise on the restructuring of the healthcare system.
We cooperate with sector organisations in consultation over legislative bills, preparing, e.g. opinions on whether bills comply with the Constitution and international law; we also participate in drawing up such regulations.
Our awareness of market practice enables us to render advice that gives a high level of legal safety and that is also effective in business terms. Where legal risks are identified, we try to propose solutions that will not only mitigate these risks but also achieve goals as near as possible to the client’s original intentions.
We run a legal blog where we regularly comment on legal changes affecting our clients' activity.
Event | 08.06.2021 During the webinar Anna Partyka-Opiela and Klaudia Sałdan from DZP's Compliance Team will show you what the idea of Legal Design is all about, what its main assumptions are and what results can you expect from the modification of legal documents in the organization.
Deals corner | 21.05.2021 Thanks to the transaction, the German investor acquired a new production plant and reliable suppliers, which will enable it to further implement its growth strategy. Our advice covered all stages of the transaction.
News | 15.04.2021 A new edition of the Legal 500 EMEA publication and ranking has just been published. We are pleased to inform you that our law firm and experts were recognised again.
News | 13.04.2021 We are pleased to announce that DZP's Life Sciences Practice has been nominated for ranking awards in two categories. In addition, Michał Czarnuch and Tomasz Kaczyński also have a chance to gain individual distinctions.
Event | 25.03.2021 On 25 March we invite you to the Whistleblowing Special - CEE Event, which will be held online. The event will focus on the Whistleblower Protection Act, which will come into force in December 2021.
News | 18.03.2021 We are pleased to announce that both DZP and our experts have once again been recommended in the Chambers Europe 2021 ranking that was published on 18th March.
Deals corner | 22.12.2020 DZP is supporting Boehringer Ingelheim in work on improving the transparency of internal documents. Boehringer Ingelheim is one of the first pharmaceutical companies in Poland to decide to apply legal design methodology.
News | 18.12.2020 On 17 December, the 2020 Compliance Awards gala was held, organised by the Compliance Institute. We are pleased to announce that Anna Partyka-Opiela was named 2020 Compliance Adviser of the Year.
Event | 26.11.2020 On 26th November 2020 we invite you to the European ethics, compliance & integrity forum, organised by Institute Compliance, which will be held online.
News | 01.07.2020 We are pleased to announce that on 1 July 2020 Marcin Pieklak joined the group of our Law Firm’s Partners. He is associated with the Life Sciences Practice where he set up and is developing DZP’s reimbursement team.
News | 01.07.2020 On 1 July 2020, Salwador Milczanowski joined DZP's compliance team. He specialises in compliance issues and issues relating to the personal liability of management, particularly from the perspective of criminal and tax crime law.
Event | 22.04.2020 Dr Anna Partyka-Opiela was amongst the experts invited to share their experiences on how compliance and ethics could be helpful in the times of crisis.
News | 12.03.2020 We are pleased to announce that both DZP and our experts have once again been recommended in the Chambers Europe 2020 ranking that was published on 12th March. As in previous years, the assessment criteria for lawyers were primarily projects completed and a professional approach to clients, whose opinions are the most important factor.
Event | 10.11.2019 During the event Michał Czarnuch will take part in Panel 3: European pharmaceutical pricing regulation – opportunities and barriers for new Chinese players entering the market.
Deals corner | 16.04.2019 DZP has advised a company in the Kiwa group, Kiwa Inspecta Holding Polska sp. z o.o., on a transaction to acquire 100% of shares in Agro Quality Support Polska sp. z o.o.
News | 11.04.2019 A new edition of Legal500 EMEA has been just published. We are very pleased to inform you that once again both our law firm and individual experts have been recommended in several categories.
Event | 23.11.2018 Poland 2.0 Summit is an annual conference for professionals and students that aims to present how innovation and technological progress are transforming the future of life, business, and public policy; placing a special emphasis on the role of Poland as a promising player in this field.
Alert | 22.10.2018 In the Government Legislative Centre a new Act has been published on the liability of collective entities. It replaces the current ineffective regulation.
Alert | 14.09.2018 It imposes further obligations on collective entities and tightens up the rules for their liability under the new provisions.
Publication | 14.06.2018 The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
Event | 15.05.2018 Vitafoods will take place on 15-17 May in Geneva. During the event Michał Tracz will give a presentation: "Self-regulation in food supplements advertisement - universal learnings from Polish success story".
News | 20.03.2018 On March 20-21, we invite you to Nairobi, Kenya, to the first ever and only event of this type this year - 1st Kenya - Poland eHealth Summit! DZP will be represented by Piotr Najbuk.
News | 12.03.2018 We are very pleased to announce that both our law firm and our experts have once again been recommended in the Chambers Europe 2018 ranking that was published last week.
Deals corner | 11.10.2017 We advised the Oncology Centre in Wrocław on implementing the new ISO 37001:2016 standard. It's the first hospital and one of the first entities in Poland to decide to implement the new standard.
Publication | 01.07.2017 The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
Publication | 01.07.2017 The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
News | 08.05.2017 DZP’s Food Law Team has been enhanced by Monika Zagrajek, specialist in food law with special focus on dietary supplements, fortified foods and foods for particular uses.
News | 10.04.2017 An expanded, i.e. European, part of the Chambers and Partners ranking has just been published. The Europe Guide is a supplement to the Global Guide, and also distinguishes DZP and its experts.
News | 24.03.2017 Yesterday evening Polityka Insight announced the results of its second Ranking of Regulatory Law Firms. We are pleased to inform you that DZP has been distinguished in 5 out of 6 categories.
Deals corner | 30.01.2017 On 13 December the NAC dismissed PGF Urtica's appeal against the tender result for the anti-pneumococcal vaccines announced by the Public Procurement Department at the Ministry of Health.
Publication | 01.11.2016 Overview of distribution and marketing of drugs law (pre-conditions for distribution, licensing, wholesale distribution, marketing to consumers and professionals and engagement with patient organisations).
Publication | 01.11.2016 Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).
News | 21.10.2016 On 20 October 2016 our Law Firm signed an agreement with Microsoft. Our cooperation is aimed at providing full-range support to start-ups in the healthcare sector.
News | 06.10.2016 On 5 October 2016 the Supreme Administrative Court (SAC) passed a judgment that followed a pro-constitutional interpretation, favourable for patients, of the Reimbursement Act, overturning current SAC case law in cases of this type.
News | 05.10.2016 The Human Rights Ombudsman has set up a Healthcare Experts Committee and has invited doctors and specialists involved in the functioning of the healthcare system to participate. Dr Tomasz Zalasiński has been appointed co-chairman of the Committee.
Deals corner | 18.07.2016 USP Zdrowie Group acquired 100% of shares in the Polish-Swedish Naturell Group. We were the main adviser and co-ordinated the Polish-Swedish team of lawyers and tax and financial advisers.
News | 01.07.2016 Michał Czarnuch and Tomasz Kaczyński, who have been associated with the Life Sciences Practice for years now, have become partners in DZP as of 1 July.
News | 26.04.2016 An expanded, i.e. European, part of the Chambers and Partners ranking has just been published. The Europe Guide is a supplement to the Global Guide results published in March and also distinguishes DZP and its experts again.
News | 15.02.2016 The judgment passed by the VAC in Warsaw could lead to a change favourable for patients in how reimbursement regulations are interpreted. VAC upheld the position we put forward in the appeal against the Minister of Health’s decision.
News | 29.01.2016 28 January 2016 Polityka Insight announced the results of its first Ranking of Regulatory Law Firms 2016. Our law firm has been distinguished in three out of five categories: Pharmaceutical, Banking, Energy.
Event | 27.10.2015 On 27 October in Brussels the European Federation of Associations of Health Product Manufacturers (EHPM) is holding workshops on Food Supplements during which experts from DZP’s Life Sciences Practice are to speak.
Deals corner | 23.10.2015 Maspex Wadowice Group purchased shares in Sequoia sp. z o.o. from a minority shareholder, Sorabot investment fund. Our Law Firm acted for the Sequoia majority shareholders.
News | 14.08.2015 In June, we announced that Michał Tracz had been appointed to the Ethics Committee of the Polish Council for Supplements and Nutritional Foods (KRSiO). Today, we announce that he has been elected its Chairman.
Deals corner | 23.07.2015 We have advised Mr Maciej Sadowski, founder and owner of Magodent sp. z o.o. , which runs two hospitals, upon the sale of eighty percent of shares to LUX MED Group.
News | 01.06.2015 We are pleased to inform you that Michał Tracz, Associate with our Life Sciences Practice, has been appointed as a member of the Ethics Commission of the Polish Council for Supplements and Nutritional Foods.
Deals corner | 26.05.2015 DZP advised GlaxoSmithKline in a three-part conditional transaction with Novartis AG in the following areas: health care means (Consumer Healthcare), vaccinations and cancer medicines.
Deals corner | 02.04.2015 On February saw the publication of a regulatory report drawn up by a team led by Marcin Matczak, Tomasz Zalasiński and Michał Czarnuch on the request of the Supreme Medical Chamber.
News | 25.04.2014 Yestarday the European edition of Chambers & Partners was published. We are pleased to inform you that both our law firm and DZP’s experts have again been recommended in the following categories:
News | 10.03.2014 We are pleased to inform you that our law firm has become a supporting member of the Polish Council for Supplements and Nutritional Foods. DZP will be represented at the Association by Tomasz Kaczyński.
News | 26.11.2013 A conference was held on 26 November together with an experts' debate on "Additional health insurance 2013". Additional health insurance would strengthen the public healthcare system, said experts, one of whom was Marcin Matczak.
News | 28.10.2013 We are pleased to announce that an English version of the Pharamaceutical Law and the Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devises is now available in bookshops.
Publication | 15.04.2013 Poland is on the verge of an important breakthrough. Over the next 20 years, we need to reform the healthcare system, making it ready to pick up demographic, economic and technological challenges of the future.
Publication | 15.03.2013 Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).
Publication | 13.03.2013 There are less than six months until the introduction of several new legal requirements for both manufacturers and distributors of cosmetic products.
Deals corner | 11.02.2013 DZP advised dietary supplement producer and distributor ASA Sp. z o.o. on a process to adapt its operations to EU provisions on nutrition and health claims. EU Regulation 1924/2006, which came into force on 14 December 2012, introduced significant restrictions on the use of nutrition and health claims.
Deals corner | 28.01.2013 DZP advised Sanofi Pasteur Sp. z o.o. on the development of national practice facilitating a material rise in seasonal flu vaccination coverage levels in Poland.
Deals corner | 14.01.2013 DZP provided strategic advisory to the Employers' Union of Innovative Pharmaceutical Companies INFARMA during legislative work on amendments to the Reimbursement Act.
News | 16.11.2012 We are pleased to announce that on 16 November Marcin Matczak was registered by the Board of the INFARMA Employers' Union of Innovative Pharmaceutical Companies as an expert to the Disciplinary Court.
News | 11.05.2010 It is our great pleasure to inform you that our Law Firm has for the eighth time in a row taken first place in the leading ranking of law firms published in the Rzeczpospolita newspaper on 11 May.
From 25 May 2018 the General Data Protection Regulation (GDPR) applies in Poland and other European Union countries. We would therefore like to give you several details on the subject of how DZP processes personal data.
The administrator of the personal data is Domański Zakrzewski Palinka Sp.k. (“DZP”; address: Rondo ONZ 1, 00-124 Warszawa). Data are processed for contact purposes and to impart information on changes to provisions and authority practices and on other issues, including events concerning day-to-day legal, economic and cultural issues, inter alia, by sending DZP newsletters. The above is carried out on the basis of legitimate interests, i.e. in accordance with art. 6(1)(f) of the GDPR. Data can also be processed where necessary for the conclusion or performance of a contract and for compliance with a legal obligation to which DZP is subject, i.e. pursuant to art. 6(1)(b) and (c) of the GDPR. Data can be transferred to entities with whose help DZP achieves the indicated aims, including entities maintaining IT infrastructure. Giving data is voluntary and in contractual relations is a requirement for concluding and performing a contract. It is possible to object to data processing, request access to, rectification and erasure of personal data or restriction of processing and data portability. Data are kept until an objection is made, and in contractual relations – throughout the term of the contract and thereafter for a period specified in provisions on archiving and limitations period for claims. Anyone has the right to file a complaint with the President of the Personal Data Protection Office. Questions concerning privacy at DZP can be sent to DZP’s Data Protection Inspector, Macieja Maciejewskiego, at: email@example.com.
New rules on cookies: Domański Zakrzewski Palinka sp.k., as the service provider of the www.dzp.pl website, stores and accesses cookies, i.e. small text information fles sent by a web server and stored on your hard drive, or other data storage medium of a user, for the purposes of: proper functioning of the www.dzp.pl website, confguring the www.dzp.pl website, security and reliability of the www.dzp.pl website, session monitoring, providing advertisements, personalization of the displayed information to the user, or analysis, statistics, research and website trafc auditing.